Keywords: Chronic migraine; OnabotulinumtoxinA; Prospective study; Migraña crónica; Toxina botulÃnica A; Estudio prospectivo;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Urinary bladder; Overactive; Muscarinic antagonists; Adrenergic beta-3 receptor agonists; OnabotulinumtoxinA;
Keywords: InterStim; older women; onabotulinumtoxinA; sacral neuromodulation; urgency incontinence;
Keywords: AboA; abobotulinumtoxinA; BoNT; botulinum neurotoxin; DyT; dystonic tremor; EMG; electromyography; ET; essential tremor; IncoA; incobotulinumtoxinA; NIHCGC; National Institutes of Health Collaborative Genetic Criteria; OL; open label; OnaA; onabotulinumto
Keywords: Botulinum toxin; Neurotoxin; Facial rhytids; Brow ptosis; IncobotulinumtoxinA; OnabotulinumtoxinA; Lateral canthal rhytids;
Keywords: Botulinum toxin; Bladder; OnabotulinumtoxinA; Neurogenic detrusor overactivity; Overactive bladder; Benign prostatic hyperplasia
Keywords: Chronic migraine; onabotulinumtoxinA; topiramate; prophylactic treatment; clinical meaningfulness
Keywords: Botulinum toxin; Neurotoxin; Facial rhytids; AbobotulinumtoxinA; IncobotulinumtoxinA; OnabotulinumtoxinA; RimabotulinumtoxinB;
Keywords: Neuropathic bladder; OnabotulinumtoxinA; Intravesical drug administration; Incontinence; Children
Keywords: AbobotulinumtoxinA; Benign prostatic obstruction; Bladder outflow obstruction; Botox; Botulinum toxin; Detrusor sphincter dyssynergia; Dysport; Idiopathic detrusor overactivity; Interstitial cystitis; Neurogenic detrusor overactivity; OnabotulinumtoxinA;
Keywords: OnabotulinumtoxinA; AbobotulinumtoxinA; IncobotulinumtoxinA; RimabotulinumtoxinB; Chemodenervation; Evidenced-based review;
Keywords: OnabotulinumtoxinA; AbobotulinumtoxinA; IncobotulinumtoxinA; RimabotulinumtoxinB; Chemodenervation; Dystonia;
An academic debate: OnabotulinumtoxinA for chronic migraine: PREEMPT-derived vs “customized” dosing/injection paradigm
Keywords: OnabotulinumtoxinA; Chronic migraine; PREEMPT;
Experiencia con toxina botulÃnica en la migraña crónica
Keywords: Migraña crónica; Toxina botulÃnica A; Estudio prospectivo; Chronic migraine; Onabotulinumtoxina; Prospective study;
Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial
Keywords: urinary bladder; cystitis; interstitial; pelvic pain; quality of life; female; AE; adverse event; BPS; bladder pain syndrome; CIC; clean intermittent catheterization; HD; hydrodistention; IC; interstitial cystitis; OLS; O'Leary-Sant; OnaBotA; onabotulin
OnabotulinumtoxinA detrusor injection improves female sexual function in women with overactive bladder wet syndrome
Keywords: OnabotulinumtoxinA; Overactive bladder; Female sexual dysfunction;
Efficacy and safety of single-dose onabotulinumtoxinA in the treatment of symptoms of osteoarthritis of the knee: results of a placebo-controlled, double-blind study
Keywords: Osteoarthritis; Nociceptive pain; OnabotulinumtoxinA; Intra-articular; Placebo effect;
Functional Medicinevon Brunn's Nests and Follicular Cystitis Following Intradetrusor OnabotulinumtoxinA Injections for Overactive Bladder
Keywords: OnabotulinumtoxinA; Botox; Overactive bladder; Von Brunn's Nests;
Systematic analysis of botulinum neurotoxin type A immunogenicity in clinical studies
Keywords: ABO; abobotulinumtoxinA; BoNT; botulinum neurotoxin; BoNT-A; botulinum neurotoxin type A; INCO; incobotulinumtoxinA; MDA; mouse diaphragm assay; MPA; mouse protection assay; NAb; neutralizing antibodies; ONA; onabotulinumtoxinA; Botulinum toxin; BoNT-A; I
OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial
Keywords: urinary bladder; overactive; urinary incontinence; onabotulinumtoxinA; injections; intramuscular; botulinum toxins; AE; adverse event; CIC; clean intermittent catheterization; HRQOL; health related QOL; I-QOL; Incontinence QOL; ITT; intent to treat; KHQ;
Botulinum neurotoxin type A-cleaved SNAP25 is confined to primary motor neurons and localized on the plasma membrane following intramuscular toxin injection
Keywords: 2D; 2 dimensional; BoNT/A; botulinum neurotoxin type A; ChAT; choline acetyltransferase; CNS; central nervous system; CTB AF-488; cholera toxin B subunit Alexa Fluor 488 conjugate; DAS; digit abduction score; GAD; glutamic acid decarboxylase; GFAP; glial
A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome
Keywords: urinary bladder; interstitial cystitis; botulinum toxin; liposome; pelvic pain; AE; adverse event; BPS; bladder pain syndrome; FBC; functional bladder capacity; GRA; global response assessment; IC; interstitial cystitis; ICPI; Interstitial Cystitis Proble
Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health Related Quality of Life in Patients with Overactive Bladder
Keywords: urinary bladder; overactive; urinary incontinence; onabotulinumtoxinA; botulinum toxins; quality of life; AE; adverse event; CIC; clean intermittent catheterization; HRQOL; health reality QOL; I-QOL; Incontinence-QOL; KHQ; King's Health Questionnaire; M
Urinary Biomarkers in Women with Refractory Urgency Urinary Incontinence Randomized to Sacral Neuromodulation versus OnabotulinumtoxinA Compared to Controls
Keywords: urinary bladder; urinary incontinence; urgency; biomarkers; onabotulinumtoxinA; neuropeptides; BDNF; brain-derived neutrophic factor; BMI; body mass index; CGRP; calcitonin gene-related peptide; IL; interleukin; MMP; matrix metalloproteinase; NGF; nerve g
The Efficacy and Safety of OnabotulinumtoxinA or Solifenacin Compared with Placebo in Solifenacin Naïve Patients with Refractory Overactive Bladder: Results from a Multicenter, Randomized, Double-Blind Phase 3b Trial
Keywords: urinary bladder; overactive; urinary incontinence; onabotulinumtoxinA; botulinum toxins; cholinergic antagonists; ABC; Anticholinergic versus Botulinum Toxin Comparison; AE; adverse event; CIC; clean intermittent catheterization; ITT; intent to treat; KHQ
Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence
Keywords: urinary bladder; urinary incontinence; urge; onabotulinumtoxinA; quality of life; BMI; body mass index; FCI; Functional Comorbidity Index; HRQoL; health related QoL; HUI-3; Health Utility Index-3; OABq; Overactive Bladder Questionnaire; OABq-SF; OABq-Shor
Research PaperEffects of onabotulinumtoxinA on cardiac function following intradetrusor injections
Keywords: Autonomic cardiac function; Botulinum toxin; Heart rate variability; Intradetrusor injections; Neurogenic detrusor overactivity; onabotulinumtoxinA; Spinal cord injury; Systemic side effects;
A cross-sectional structured survey of patients receiving botulinum toxin type A treatment for blepharospasm
Keywords: BoNT; botulinum neurotoxin; BoNT/A; botulinum neurotoxin type A; BSDI; Blepharospasm Disability Index; CD; cervical dystonia; JRS; Self-administered Jankovic Rating Scale; SD; standard deviation; AbobotulinumtoxinA; Blepharospasm; Botox; Dysport; Incobotu
Research PaperImpairment of sensory afferents by intrathecal administration of botulinum toxin A improves neurogenic detrusor overactivity in chronic spinal cord injured rats
Keywords: ATF3; activating transcription factor 3; CGRP; calcitonin gene-related peptide; cSNAP-25; cleaved SNAP-25; DRG; dorsal root ganglia; IT; intrathecal; NDO; neurogenic detrusor overactivity; Onabot/A; OnabotulinumtoxinA; SCI; spinal cord injury; Spinal cord
Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of Treatment
Keywords: urinary bladder, neurogenic; onabotulinumtoxinA; urinary incontinence; quality of life; urinary tract infectionsACH, anticholinergic; AE, adverse event; CIC, clean intermittent catheterization; DOE, duration of effect; MS, multiple sclerosis; NDO, neuroge
Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study
Keywords: urinary bladder, overactive; urinary incontinence; onabotulinumtoxinA; quality of life; urinary tract infectionsAE, adverse event; CIC, clean intermittent catheterization; MID, minimally important difference; OAB, overactive bladder syndrome; PVR, post-vo
Original ArticleOnabotulinumtoxinA Improves Pain in Patients With Post-Stroke Spasticity: Findings From a Randomized, Double-Blind, Placebo-Controlled Trial
Keywords: OnabotulinumtoxinA; pain; post-stroke spasticity; disability;
In-vivo comparison of the neurotoxic potencies of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA
Keywords: BoNT; botulinum neurotoxin; BoNT/A-G; botulinum neurotoxin type A-G; A/Inco; incobotulinumtoxinA (Xeomin®); A/Ona; onabotulinumtoxinA (Botox®); A/Abo; abobotulinumtoxinA (Dysport®); DAS assay; digit abduction score assay; MU; mouse unit; Vmax; maximum
Hemiparetic gait and changes in functional performance due to OnabotulinumtoxinA injection to lower limb muscles
Keywords: Gait analysis; Hemiparesis; OnabotulinumtoxinA; Spasticity
Primary results from the Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE)
Keywords: Cervical dystonia; Botulinum toxin; OnabotulinumtoxinA; Torticollis; Pain;
Effect of onabotulinumtoxinA treatment on symptoms and urodynamic findings in pediatric neurogenic bladder
Keywords: OnabotulinumtoxinA; Botox; Neurogenic bladder; Children
OnabotulinumtoxinA (Botox) Nerve Blocks Provide Durable Pain Relief for Men with Chronic Scrotal Pain: A Pilot Open‐Label Trial
Keywords: Botox; Chronic Scrotal Pain; OnabotulinumtoxinA
Optimum Management of Overactive Bladder: Medication vs Botox® vs InterStim® vs Urgent® PC
Keywords: urinary bladder; overactive; onabotulinumtoxinA; mirabegron; cholinergic antagonists; surgery; FDA; Food and Drug Administration; OAB; overactive bladder;
Treatment of depression with onabotulinumtoxinA: A randomized, double-blind, placebo controlled trial
Keywords: OnabotulinumtoxinA; Depression; Double blind; Clinical trial; Antidepressant; Corrugator
Bladder Instillation of Liposome Encapsulated OnabotulinumtoxinA Improves Overactive Bladder Symptoms: A Prospective, Multicenter, Double-Blind, Randomized Trial
Keywords: onabotulinumtoxinA; liposomes; urinary bladder; overactive; AE; adverse event; BoNT; botulinum toxin; GRA; global response assessment; OAB; overactive bladder; OABSS; OAB symptom scores; onaBoNTA; onabotulinumtoxinA; PVR; post-void residual; Qmax; maximum
A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of OnabotulinumtoxinA 200 U to Treat Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia
Keywords: prostate; prostatic hyperplasia; lower urinary tract symptoms; onabotulinumtoxinA; benign prostatic hyperplasiaAE, adverse event; BPH, benign prostatic hyperplasia; BPHII, BPH Impact Index; IIEF, International Index of Erectile Function; I-PSS, Internatio
Traitement de l'incontinence urinaire masculine non neurologique par hyperactivité vésicale : une revue de la littérature du CTMH de l'AFU
Keywords: Hyperactivité vésicale; Incontinence urinaire masculine; Urgenturies; Anticholinergiques; OnabotulinumtoxinA; Neurostimultion; Entérocystoplastie; Overactive bladder; Male urinary incontinence; Urgency; Antimuscarinic; OnabotulinumtoxinA; Neurostimulat
OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline
Keywords: Medication overuse; Chronic migraine; Botulinum toxin type A; OnabotulinumtoxinA; Prophylactic treatment; Health-related quality of life;
Featured contentOriginal researchEstimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States
Keywords: cost-effectiveness; neurogenic detrusor overactivity; onabotulinumtoxinA;
Long-term clinical value of urethral sphincter injection of onabotulinumtoxinA for patients with acontractile bladder
Keywords: acontractile bladder; onabotulinumtoxinA; subjective outcomes; urethral sphincter injection
Persistent Therapeutic Effect of Repeated Injections of Onabotulinum Toxin A in Refractory Bladder Pain Syndrome/Interstitial Cystitis
Keywords: cystitis; interstitial; onabotulinumtoxinA; urinary bladder; painBPS/IC, bladder pain syndrome/interstitial cystitis; FVC, 3-day frequency volume chart; OnabotA, onabotulinum toxin A; OSS, O'Leary-Sant score; QoL, quality of life; UTI, urinary tract infec
Increased Risk of Large Post-Void Residual Urine and Decreased Long-Term Success Rate After Intravesical OnabotulinumtoxinA Injection for Refractory Idiopathic Detrusor Overactivity
Keywords: urinary bladder, overactive; onabotulinumtoxinA; frail elderly; quality of life; complicationsAE, adverse events; AUR, acute urinary retention; BCI, bladder contractility index; BoNT-A, onabotulinumtoxinA; CBC, cystometric bladder capacity; CIC, clean int
A Randomized Double-blind Placebo-controlled Phase 2 Dose-ranging Study of OnabotulinumtoxinA in Men with Benign Prostatic Hyperplasia
Keywords: Benign prostatic hyperplasia; Lower urinary tract symptoms; Botulinum toxin; OnabotulinumtoxinA; Quality of life
OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial
Keywords: Botulinum toxin; OnabotulinumtoxinA; Overactive bladder; Urinary incontinence
OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial
Keywords: urinary bladder; overactive; urinary incontinence; onabotulinumtoxinA; injections; intramuscular; botulinum toxinsAE, adverse event; CIC, clean intermittent catheterization; HRQOL, health related QOL; I-QOL, Incontinence QOL; ITT, intent to treat; KHQ, Ki